Abstract
Cardiologists did not regard coronary heart disease as an important part of their specialty until well after the second world war. General practitioners or general physicians cared for most patients with angina and myocardial infarction, and it was not until the advent of coronary care units and the development of techniques such as arteriography and echocardiography that it was appreciated (at least in the United Kingdom) that cardiologists had an essential role in the diagnosis and management of coronary heart disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References and notes
Peel AAF. Diseases of the heart. London: Oxford University Press, 1947:292.
Wood P. Diseases of the heart and circulation. London: Eyre and Spottiswoode, 1950.
Lewis T. Disease of the heart. 3rd ed. London: Macmillan, 1946:60.
Wood P. Diseases of the heart and circulation. 2nd ed. London: Eyre and Spottiswoode, 1956 (reprinted 1959).
Wright IS, Marple CD, Beck DF. Report of the committee for the evaluation of anticoagulants in the treatment of coronary thrombosis with myocardial infarction. Am Heart J 1948;36:801–15.
Gilchrist AR, Tulloch JA. Anticoagulants in coronary disease. BMJ 1954;2:720.
Griffiths GC. The treatment of shock associated with myocardial infarction. Circulation 1954;9:527–32.
Peel AAF, Semple T, Wang I, Lancaster WM, Dall JLC. A coronary prognostic index for grading the severity of myocardial infarction. Br Heart J 1962;24:745–60.
Norris RM, Brandt PWT, Caughey DE, Lee AJ, Scott PJ. A new coronary prognostic index. Lancet 1969;i:278–81.
Kouwenhoven WB, Jude JR, Knickerbocker GG. Closed-chest cardiac massage. JAMA 1960;173:1064–7.
Julian DG. Treatment of cardiac arrest in acute myocardial ischaemia and infarction. Lancet 1961;ii:840–4.
Thomas M, Malmcrona R, Shillingford JP. Hemodynamic changes in patients with acute myocardial infarction. Circulation 1965;31:811–8.
Mackenzie GJ, Taylor SH, Flenley DC, McDonald AH, Staunton HP, Donald KW. Circulatory and respiratory studies in myocardial infarction and cardiogenic shock. Lancet 1964;ii:825–8.
Cochrane AL. Effectiveness and efficiency. London: Nuffield Hospital Trust, 1972.
Rose G. The contribution of intensive coronary care. Br J Prev Soc Med 1965;29:147–50.
Oliver MF, Julian DG, Donald KW. Problems in evaluating coronary care units. Am J Cardiol 1967;20:465–74.
Mather HG, Morgan DC, Pearson NG, et al. Myocardial infarction: a comparison between home and hospital care for patients. BMJ 1976;1:925–9.
Hill JD, Hampton JR, Mitchell JRA. A randomised trial of home versus hospital management for patients with suspected myocardial infarction. Lancet 1978;i:837–41.
Lie KI, Wellens HJJ, Downar E, Durrer D. Observations on patients with primary ventricular fibrillation complicating myocardial infarction. Circulation 1975;52:75–9.
Campbell RWF, Murray A, Julian DG. Ventricular arrhythmias in first 12 hours of acute myocardial infarction. Br Heart J 1981;46:351–7.
Pantridge JF, Geddes JS. A mobile coronary care unit in the management of myocardial infarction. Lancet 1967;ii:271–3.
ISIS-4 Collaborative Group. Fourth international study of infarct survival. A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. Lancet 1995;435:669–85.
Gruppo Italiano per lo Studio Suprawivenza nell’infarto Miocardico. GISSI-3. Effect of lisinopril and transdermal glyceryl trinitrate singly and together on 6 week mortality and ventricular function after acute myocardial infarction. Lancet 1994;343:1115–22.
ISIS-1 Collaborative Group. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 1986;ii:57–66.
Woods KL, Ketley D, Lowy A, et al. (3-blockers and antithrombotic treatment for secondary prevention after acute myocardial infarction. Eur Heart J 1998;19:74–9.
ISIS-2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17 187 cases of suspected acute myocardial infarction. ISIS-2. Lancet 1988;i:349–60.
Gruppo Italiano per lo Studio Delia Streptokinase Nell’infarto Miocardico.(GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;i:397–402.
ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction. Lancet 1992;339:753–70.
The International Study Group. In-hospital mortality and clinical course of 20 891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin. Lancet 1990;336:71–5.
The GUSTO Investigators. An international randomized trial comprising four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673–82.
Weston CF, Penny WJ, Julian DG. Guidelines for the early management of patients with myocardial infarction. British Heart Foundation Working Group. BMJ 1994;308:767–71.
GREAT Group. Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners. Grampian region early anistreplase trial. BMJ 1992;305:548–53.
Birkhead JS. Thrombolytic treatment for myocardial infarction; an examination of practice in 39 United Kingdom hospitals. Myocardial Infarction Audit Group. Heart 1997;78:28–33.
Norris RM. Sudden cardiac death and acute myocardial infarction in three British health districts, The UK heart attack survey. London: British Heart Foundation, 1999.
Medical Research Council. Second report of the working party on anticoagulant therapy in coronary thrombosis. BMJ 1964;2:837–43.
Mitchell JRA. Anticoagulants in coronary disease-retrospect and prospect. Lancet 1981;i:257–62.
Multicentre International Study. Improvement in prognosis of myocardial infarction by long-term β-adrenoceptor blockade using practolol. BMJ 1975;3:735–40.
Baber NS, Wainwright Evans D, Howitt G, et al. A multicentre propranolol post-infarction trial in 49 hospitals in the United Kingdom, Italy and Yugoslavia. Br Heart J 1980;44:419–21.
Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving myocardial infarction. N Engl J Med 1981;304:801–7.
Beta-blocker Heart Attack Study Group (BHAT). A beta-blocker heart attack trial. JAMA 1981;246:2073–74.
Chamberlain DA, Jewitt DE, Julian DG, et al. Oral mexiletine in high-risk patients after myocardial infarction. Lancet 1980;ii:1324–7.
The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821–8.
Pfeffer MA, Braunwald E, Moyé LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992;327:669–77.
Kober L, Torp-Pedersen, C, Carlsen JE, et al. for the Trandolapril Cardiac Evaluation Study Group. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995;333:1670–4.
Heberden W. Some account of a disorder of the breast. Med Trans R Coll Physicians Lond 1772;2:59.
Herrick JB. Clinical features of sudden obstruction of the coronary arteries. JAMA 1912;59:2015–20.
Stowers M, Short D. Warning symptoms before major myocardial infarction. Br Heart J 1970;32:833–8.
Wood P. Acute and subacute coronary insufficiency. BMJ 1961;1:1779–82.
Krauss KR, Hutter AM Jr, De Sanctis RW. Acute coronary insufficiency: course and follow-up. Circulation 1972;45(suppl I):66–71.
Fulton M, Duncan B, Lutz W, et al. Natural history of unstable angina. Lancet 1972;i:860–4.
Fulton M, Julian DG. Unstable angina. In: Julian DG ed. Angina pectoris. Edinburgh: Churchill Livingstone, 1977.
Lewis HD Jr, Davis JW, Archibald DG, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. N Engl J Med 1983;309:396–403.
Cairns JA, Gent M, Singer J, et al. Aspirin, sulfinpyrazone or both in unstable angina. N Engl J Med 1985;313:1369–75.
The Holland Interuniversity Nifedipine/Metoprolol Trial (HINT) Research Group. Early treatment of unstable angina in the coronary unit. Br Heart J 1986;56:400–13.
Adams PC, Skinner JS, Cohen M, McBride R, Fuster V. Acute coronary syndromes in the United States and the United Kingdom: a comparison of approaches. The Antithrombotic Therapy in Acute Coronary Syndromes Research Group. Clin Cardiol 1998;21:348–52.
Prinzmetal M, Kennamar R, Merliss R, Wada T, Bor N. A variant form of angina pectoris. Am J Med 1959;27:375–88.
Maseri A, Severi S, Nes MD, et al. Variant angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriography findings in 138 patients. Am J Cardiol 1978;42:1019–35.
Master AM, Rosenfeld I. Two-step exercise test: current status after 25 years. Modern Concepts Cardiovasc Dis 1967;36:19–24.
Balcon R, Maloy WE, Sowton E. Clinical use of atrial pacing test in angina pectoris. BMJ 1968;610:91–2.
Sones FM Jr, Shirey EK. Cine coronary arteriography. Modern Concepts Cardiovasc Dis 1962;31:735–38.
European Coronary Surgery Study Group. Coronary artery bypass surgery in stable angina pectoris: survival at two years Lancet 1979;ii:889–93.
Grüntzig AR. Transluminal dilatation of coronary artery stenosis Lancet 1978;i:263.
Working Party of the Joint Audit Committee of the British Cardiac Society and the Royal College of Physicians of London. The investigation and management of stable angina pectoris. J R Coll Physicians 1993;27:267–73.
De Bono D for the Joint Working Party of the British Cardiac Society and the Royal College of Physicians of London. Investigation and management of stable angina: revised guidelines 1998. Heart 1999;81:546–55.
Sculpher MJ, Pettigrew M, Kelland JL, Elliott RA, Holdright DR, Buxton MJ. Resource allocation for chronic stable angina: a systematic review of effectiveness, costs, and cost-effectiveness of alternative interventions. Health Technol Assess 1998;2:10.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Spinger-Verlag London Limited
About this chapter
Cite this chapter
Julian, D. (2000). Clinical Coronary Heart Disease. In: Silverman, M.E., Fleming, P.R., Hollman, A., Julian, D.G., Krikler, D.M. (eds) British Cardiology in the 20th Century. Springer, London. https://doi.org/10.1007/978-1-4471-0773-6_28
Download citation
DOI: https://doi.org/10.1007/978-1-4471-0773-6_28
Publisher Name: Springer, London
Print ISBN: 978-1-4471-1199-3
Online ISBN: 978-1-4471-0773-6
eBook Packages: Springer Book Archive